➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: June 19, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Tyramine

Email this page to a colleague

« Back to Dashboard

What is the drug development status for Tyramine?

Tyramine is an investigational drug.

There have been 18 clinical trials for Tyramine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2016.

The most common disease conditions in clinical trials are Hypercholesterolemia, Depressive Disorder, and Depression. The leading clinical trial sponsors are Sanofi, Regeneron Pharmaceuticals, and Celgene.

Recent Clinical Trials for Tyramine
A Clinical Study to Assess the Effect of Change of Bile Acid on the PD and Safety of Metformin and Microbiome ProfilesSeoul National University HospitalN/A
Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver DiseaseEA Pharma Co., Ltd.Phase 2
Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver DiseaseYokohama City UniversityPhase 2

See all Tyramine clinical trials

Clinical Trial Summary for Tyramine

Top disease conditions for Tyramine
Top clinical trial sponsors for Tyramine

See all Tyramine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.